Home > Products > CEA & DR5
> Anti-CEA x Anti-DR5 Bispecific Antibody (IgG-IgG)
Anti-CEA x Anti-DR5 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-136)
Anti-CEA x Anti-DR5 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CEA and anti-DR5 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can induce targeted apoptosis by activation of the death receptor. It is designed for the research of Breast cancer; Ovary cancer; Colon cancer; Lung cancer therapy.
There are currently no customer reviews or questions for Anti-CEA x Anti-DR5 Bispecific Antibody (IgG-IgG) (BSIG-136). Click the button below to contact us or submit your feedback about this product.